Search results
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity ...
Motley Fool via Yahoo Finance· 2 days agoEli Lilly's Zepbound/Mounjaro Eli Lilly (NYSE: LLY) won U.S. regulatory approval for Zepbound in...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 4 days agoWith its stock price fast approaching $1000 per share, drugmakerEli lilly is poised for a forward...
A Surprise Big Name Enters The Weight-Loss Melee
Investor's Business Daily· 1 day agoInstead, the company posted the results from testing in monkeys in...indeed, Gilead has an oral GLP-1 approaching Phase 1." Over the course of 36 days,...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 4 days agoA key advisory panel for the Food and Drug Administration on Monday recommended donanemab, Eli Lilly...
Kansas City lawyer becomes co-lead counsel in national weight-loss drug lawsuit - Kansas City...
The Business Journals· 2 days agoA Kansas City lawyer is helping lead a class-action lawsuit against Novo Nordisk and Eli Lilly,...
Employer coverage for weight-loss drugs rises sharply, survey finds By Reuters
Investing.com· 2 days agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...
A new Alzheimer's drug, combined COVID and flu vaccine update, and salmonella concerns. 3 health...
Yahoo Life Style via AOL· 14 hours agoWant more? Read the guide I put together on foodborne illnesses. ⚕️ A new Alzheimer's drug just...
...Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed...NVIDIA (NASDAQ:NVDA), Eli Lilly and...
Benzinga· 4 days agoJim Cramer has expressed his confidence in Eli Lilly and Co LLY, citing the company’s diverse drug...
A Deep Dive into the New Amplify Weight Loss Drug & Treatment ETF (THNR) | Investing.com
Investing.com· 6 days agoETF investors are quick to jump from one trend to another, and the latest focus is on companies...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy? | The Motley Fool
The Motley Fool· 5 days agoJohnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth...
